Call Options Transactions Made in Q2 2023 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q2 2023. The information is specifically focused on institutions that hold call options of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
266K+ 1062.0% |
$4.78M - $7.8M
|
291K
$11.8M
|
|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
54KNew |
$973K - $1.59M
|
54K
$2.2M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
30.5KNew |
$550K - $895K
|
30.5K
$1.24M
|
|
|
Aug 14, 2023
Q2 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
1.9K+ 146.15% |
$34.2K - $55.8K
|
3.2K
$130K
|
|
|
Aug 14, 2023
Q2 2023
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
CALL |
-3.1K- 7.18% |
$55.9K - $91K
|
40.1K
$1.63M
|
|
|
Aug 14, 2023
Q2 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-3.2K- 60.38% |
$57.7K - $94K
|
2.1K
$85.4K
|
|
|
Aug 14, 2023
Q2 2023
|
Moore Capital Management, LP
New York, NY |
SELL
|
CALL |
-5K- 20.0% |
$90.1K - $147K
|
20K
$814K
|
|
|
Aug 08, 2023
Q2 2023
|
Belvedere Trading LLC
|
SELL
|
CALL |
-9.7K- 57.4% |
$175K - $285K
|
7.2K
$293K
|
|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
CALL |
-11.4K- 5.39% |
$205K - $335K
|
200K
$8.14M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-51.1K- 12.79% |
$921K - $1.5M
|
348K
$14.2M
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-207K- 34.41% |
$3.73M - $6.07M
|
394K
$16M
|